KLK3 and benign prostatic hyperplasia: Though PSA has emerged as marker for prostatic conditions like P.Ca and BPH in the past decade, there has been an increasing realization by both biochemists and urologists, to have a better single marker or a combination of biochemical tests to differentiate the above conditions, to avoid frequency and unnecessary biopsies in nonmalignant conditions.